BIOVIE INC.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Aug 13, 2026

BIVI$1.30-2.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page

PART I

Item 1. Business Item 1A. Risk Factors Item 1B. Unresolved Staff Comments Item 1C. Cybersecurity Item 2. Properties Item 3. Legal Proceedings Item 4. Mine Safety Disclosures

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 6. [Reserved] (no text here)

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk (no text here)

Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (no text here)

PART III

Item 10. Directors, Executive Officers and Corporate Governance (no text here)

Item 11. Executive Compensation (no text here)

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters (no text here)

Item 13. Certain Relationships and Related Transactions, and Director Independence (no text here)

Item 14. Principal Accountant Fees and Services (no text here)

PART IV

Item 15. Exhibits and Financial Statement Schedules

Item 16. Form 10-K Summary

24.1*Power of Attorney (included on signature page to this report)Report of Independent Registered Public Accounting Firm – EisnerAmper LLP (PCAOB Number 274)Balance Sheets Statements of Operations Statements of Changes in Stockholders’ Equity Statements of Cash Flows Notes to Financial Statements

Statements of Cash Flows

	Year Ended	Year Ended
	June 30, 2026	June 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$(22,072,863)	$(17,542,120)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of intangible assets	178,341	229,377
Stock based compensation - restricted stock units and restricted shares	589,710	1,202,809
Stock based compensation expense - stock options	2,283,809	1,195,447
Stock based compensation expense - issuance of common stock for services rendered	-	73,680
Amortization of financing costs	-	11,820
Accretion of unearned loan discount	-	111,212
Accretion of loan premium	-	25,758
Non-cash lease expense from right-of-use asset	77,067	67,073
Change in fair value of derivative liabilities	-	(3,771)
Changes in operating assets and liabilities:
Grant receivable	(47,390)	(2,104,050)
Prepaid and other current assets	(1,463,458)	(845,505)
Accounts payable and accrued expenses	1,504,442	(1,386,592)
Operating lease liability	(74,464)	(60,343)
Net cash used in operating activities	(19,024,806)	(19,025,205)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock	10,457,629	15,674,613
Proceeds from exercise of warrants	-	2,901,341
Payment of loan premium	-	(850,000)
Payment of note payable	-	(5,000,000)
Net cash provided by financing activities	10,457,629	12,725,954
Net change in cash and cash equivalents	(8,567,177)	(6,299,251)
Cash and cash equivalents, beginning of period	17,544,547	23,843,798
Cash and cash equivalents, end of period	$8,977,370	$17,544,547
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	$17,901	$183,930
SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES:
Deemed dividend for ratchet adjustment to warrants	$43,544	$369,465

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.